5d • General discussion
SS-31 Possible New Names
1. The Official FDA Name Change (The "Cease and Desist" Cause)
The primary reason you may be seeing name changes or product removals is that SS-31 received FDA approval in September 2025.
- New Brand Name: Forzinity
- Generic Drug Name: Elamipretide
- Indication: Barth Syndrome (specifically to improve muscle strength).
- Manufacturer: Stealth BioTherapeutics.
Why this matters: Once a peptide becomes an approved FDA drug (Forzinity), it is legally removed from the compounding/research chemical "exempt" list. This triggers cease-and-desist letters to vendors, forcing them to stop selling it or change the name to hide it.
2. Alternative Names (Research & Gray Market)
If you are looking for SS-31 on research sites (like Peptira or others) and cannot find it, they may have relisted it under one of its chemical synonyms to avoid automated filters:
- Elamipretide (The most common chemical name)
- MTP-131 (An older development code)
- Bendavia (A previous potential trade name)
- D-Arg-Dmt-Lys-Phe-NH2 (The chemical structure often used on labels)
7
7 comments
SS-31 Possible New Names
powered by
skool.com/peptide-price-9771
Premier peptide education hub. FREE courses on research peptides & GLP-1s. US supplier intel, safety protocols & expert community support. 🧬🚀
Suggested communities
Powered by